sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
gauacugucuaagaauaauga | 2985 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaauagaucuucccugaaagaga | 2456 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaauagaucuucccugaaagaga | 2456 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaauagaucuucccugaaagaga | 3521 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uaauagaucuucccugaaagaga | 3521 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
guccuagguuuauuuugcagacu | 719 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
guccuagguuuauuuugcagacu | 719 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
guccuagguuuauuuugcagacu | 269 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
guccuagguuuauuuugcagacu | 269 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1396 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1396 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1694 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1694 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1653 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1653 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1437 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaccuaagugacuaccaca | 1437 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1773 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1773 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1478 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1478 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1516 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1516 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1735 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggcacauuggaacugagcacu | 1735 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uccucuauguagguuccaaaacu | 1150 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uccucuauguagguuccaaaacu | 1150 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 2951 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 2951 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 1886 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 1886 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 3144 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 3144 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 2079 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ccaucagcagugauugaagua | 2079 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aagcugcaugugucaucuuacac | 2878 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aagcugcaugugucaucuuacac | 2878 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aagcugcaugugucaucuuacac | 2698 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aagcugcaugugucaucuuacac | 2698 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1405 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1405 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1448 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1448 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1705 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1705 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 2991 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 2991 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1662 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1662 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1926 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacuaugcaccuauaaauaa | 1926 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agccauggauguauucaugaa | 3118 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agccauggauguauucaugaa | 3118 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agccauggauguauucaugaa | 2053 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agccauggauguauucaugaa | 2053 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agccuaagaaauaucuuugcucc | 2576 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agccuaagaaauaucuuugcucc | 2576 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cagucaugacauuucucaaaguu | 2861 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cagucaugacauuucucaaaguu | 2861 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cagucaugacauuucucaaaguu | 2591 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cagucaugacauuucucaaaguu | 2591 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaagaggguguucucuauguag | 196 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaagaggguguucucuauguag | 196 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaagaggguguucucuauguag | 646 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaagaggguguucucuauguag | 646 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaagaggguguucucuauguag | 1099 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaaagaggguguucucuauguag | 1099 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaggaaaugccuuuaaacaa | 1942 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaggaaaugccuuuaaacaa | 1942 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaggaaaugccuuuaaacaa | 3007 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
acaggaaaugccuuuaaacaa | 3007 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaauaagugguagucacuua | 1534 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaauaagugguagucacuua | 1534 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaauaagugguagucacuua | 1791 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uagaaauaagugguagucacuua | 1791 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucucuauguaggcuccaaaacc | 197 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucucuauguaggcuccaaaacc | 197 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucucuauguaggcuccaaaacc | 647 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucucuauguaggcuccaaaacc | 647 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacuacuacagagugcuaagcug | 2827 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacuacuacagagugcuaagcug | 2827 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1796 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1796 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1548 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1548 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1539 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1539 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1805 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uacacaaguuaauaaaacacauc | 1805 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 24 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 24 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 294 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 294 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 744 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 744 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 474 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggguaucaagacuacgaacca | 474 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gccaaauauaugaauucuaga | 1947 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gccaaauauaugaauucuaga | 1947 | CA3193830A1 | COMPOSITIONS A BASE D'ARNI DE SNCA ET LEURS PROCEDES D'UTILISATION POUR TRAITER OU PREVENIR DES MALADIES NEURODEGENERATIVES ASSOCIEES A SNCA | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gccaaauauaugaauucuaga | 3012 | CA3193830A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 2 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.